Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-23.44	-874.74	1142.56
Graham Fair Price	5.89	22.21	20.98
PEG	46.38	1.16	0.80
Price/Book	-14.97	1.18	1.38
Price/Cash Flow	-19.72	50.06	62.35
Prices/Earnings	-22.62	12.55	16.21
Price/Sales	-15.37	8.82	10.42
Price/FCF	-19.72	50.06	62.35
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.04	1.00	1.00
Operating Margin	-66.36	0.24	-0.70
ROA	10.02	< 0.005	< 0.005
ROE	0.02	0.02	9.88
ROIC	-0.05	0.02	-63.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.22	-0.10	-118.74
Dividends QOQ	-0.04	< 0.005	-99.22
EBIT QOQ	-5.19	1.34	-74.14
EPS QOQ	0.20	0.11	-47.13
FCF QOQ	-0.41	0.07	-82.55
Revenue QOQ	0.41	0.02	-96.11
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.31	0.26	-15.06
Quick Ratio	0.33	0.48	46.83
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	30.26	30.57	1.02
Cash	34.73	36.85	6.12
Capex	-0.06	-0.05	17.05
Free Cash Flow	0.67	0.72	7.00
Revenue	4.02	4.08	1.50
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.05	0.10	102.17
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	216.06	-91.83	-57.50
Naive Interpretation	Member

06 - Financial Health · Bad

Rating